Linda Yaccarino, less than a month after stepping down as CEO of Elon Musk’s X, has found her next gig. Yaccarino has been named CEO of Miami-based eMed Population Health, which calls itself “the leading digital health platform for GLP-1/GIP population health management.” That refers to the class of weight-loss drugs like Wegovy and Ozempic. […]
Linda Yaccarino, After Exiting Elon Musk’s X, Tapped as CEO of Weight-Loss Drug Management Company eMed
